Nanobiotix annonce la publication dans le Lancet Oncology des données de phase III dans le Sarcome des Tissus Mous pour NBTXR3 son produit premier d’une nouvelle classe

NEXT STORY
ABOG Appoints New Board of Directors Members, Division Chair, and Members of Subspecialty Divisions
PREV STORY
Emergency Medical Service Products Market Size Worth Around US$ 24.3 Bn by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Five Prime Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

author_avatar
NASDAQ Market News

Leading-edge Scientists in Innate Immunity Join Qu Biologics’ Scientific Advisory Board

VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical ...

author_avatar
NASDAQ Market News

Aduro Biotech to Present at the 37th Annual J.P. Morgan Healthcare Conference

BERKELEY, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today ...

author_avatar
NASDAQ Market News